Madrigal Pharmaceuticals, Inc.
IT ˙ BIT ˙ US5588681057
412,50 € 0,00 (0,00%)
2026-06-04
AKTIENPREIS
SecurityIT:1MDGL / Madrigal Pharmaceuticals, Inc.
InstitutionPrudential Financial Inc
Latest Disclosed Ownership6,941 shares
Latest Disclosed Value $ 3,633,405
Prudential Financial Inc reports 22.31% increase in ownership of 1MDGL / Madrigal Pharmaceuticals, Inc.

On May 13, 2026 - Prudential Financial Inc filed a 13F-HR form disclosing ownership of 6,941 shares of Madrigal Pharmaceuticals, Inc. (IT:1MDGL) valued at $3,083,192 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 5,675 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of 22.31% during the quarter. The current value of the position is $2,863,162 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 6,941 1,266 22.31 3,633 9.96 0.0025
2026-02-13 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 5,675 -238 -4.03 3,305 21.83 0.0040
2025-11-13 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 5,913 783 15.26 2,712 74.74 0.0032
2025-08-12 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 5,130 453 9.69 1,553 0.19 0.0020
2025-05-13 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 4,677 1,022 27.96 1,549 37.44 0.0022
2025-02-11 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 3,655 2,282 166.21 1,128 287.29 0.0015
2024-11-14 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,373 51 3.86 291 -21.35 0.0004
2024-08-13 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,322 203 18.14 370 24.16 0.0006
2024-05-14 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,119 -1 -0.09 299 15.06 0.0004
2024-02-13 2023-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,120 1,120 259 0.0004
2023-11-13 2023-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -1,039 -100.00 0 -100.00
2023-08-11 2023-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,039 -5,008 -82.82 240 -83.61 0.0003
2023-05-12 2023-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 6,047 -7,047 -53.82 1,465 -61.47 0.0023
2023-02-14 2022-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 13,094 -7,755 -37.20 3,801 180.44 0.0064
2022-11-04 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 20,849 50 0.24 1,355 -9.00 0.0023
2022-08-15 2022-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 20,799 20,799 1,489 0.0024
2020-11-16 2020-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -10,894 -100.00 0 -100.00
2020-08-12 2020-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 10,894 20 0.18 1,234 69.97 0.0024
2020-05-12 2020-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 10,874 -76 -0.69 726 -27.18 0.0016
2020-02-11 2019-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 10,950 10,950 997 0.0015
2019-02-07 2018-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 0 -1,040 -100.00 0 -100.00
2018-11-07 2018-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 1,040 210 25.30 223 -3.88 0.0003
2018-08-13 2018-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 830 830 232 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.